b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31640736</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>06</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1750-1172</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>14</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>10</Month>\n                        <Day>22</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Orphanet journal of rare diseases</Title>\n                <ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>232</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-019-1216-0</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Angelman syndrome (AS) is a neurodevelopmental disorder that is caused by maternal genetic deficiency of a gene that encodes E6-AP ubiquitin-protein ligase (gene symbol UBE3A) mapping to chromosome 15q11-q13. AS leads to stiff and jerky gait, excess laughter, seizures, and severe intellectual disability. In some parts of the brain, the paternally inherited UBE3A gene is subject to genomic imprinting by the action of the UBE3A-antisense transcript (UBE3A-ATS) on the paternally inherited allele. Consequently, only the maternally inherited UBE3A gene is expressed in mature neurons. AS occurs due to deletions of the maternal 15q11\xe2\x80\x89-\xe2\x80\x8913 region, paternal uniparental disomy (UPD), imprinting center defects, mutations in the maternal UBE3A gene, or other unknown genetic malfunctions that result in a silenced maternal UBE3A gene in the specific imprinted regions of the brain.</AbstractText>\n                <AbstractText Label="RESULTS">A potential treatment strategy for AS is to increase methylation of UBE3A-ATS to promote expression of the paternal UBE3A gene and thus ameliorate the clinical phenotypes of AS. We treated two sets of male identical twins with class I deletions with a 1 year treatment trial of either betaine and folic acid versus placebo. We found no statistically significant changes in the clinical parameters tested at the end of the 1 year trial, nor did we find any significant adverse events.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">This study tested the hypothesis that by increasing the methylation of the UBE3A-antisense transcript in Angelman syndrome to promote expression of the silenced paternal UBE3A gene we may ameliorate the clinical phenotypes of AS. We treated two sets of identical twins with placebo versus betaine and folic acid. Although this study represented a novel approach to treating Angelman syndrome, the differences in the developmental testing results was not significant. This paper also discusses the value of monozygotic twin studies in minimizing confounding variables and its utility in conducting small treatment studies.</AbstractText>\n                <AbstractText Label="TRIAL REGISTRATION">NCT00348933 . Registered 6 July 2006.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Han</LastName>\n                    <ForeName>Julia</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California at Irvine, 101 The City Drive South, Orange, CA, 92868, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bichell</LastName>\n                    <ForeName>Terry Jo</ForeName>\n                    <Initials>TJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders, Nashville, TN, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Golden</LastName>\n                    <ForeName>Stephanie</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Genetics and Metabolism, Department of Medicine, Boston Children\'s Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Anselm</LastName>\n                    <ForeName>Irina</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, Boston Children\'s Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Waisbren</LastName>\n                    <ForeName>Susan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Genetics and Metabolism, Department of Medicine, Boston Children\'s Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bacino</LastName>\n                    <ForeName>Carlos A</ForeName>\n                    <Initials>CA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Peters</LastName>\n                    <ForeName>Sarika U</ForeName>\n                    <Initials>SU</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics, Vanderbilt University, Vanderbilt Kennedy Center for Research on Human Development, Nashville, TN, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bird</LastName>\n                    <ForeName>Lynne M</ForeName>\n                    <Initials>LM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics, University of California, San Diego, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Genetics/Dysmorphology, Rady Children\'s Hospital San Diego, San Diego, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kimonis</LastName>\n                    <ForeName>Virginia</ForeName>\n                    <Initials>V</Initials>\n                    <Identifier Source="ORCID">0000-0003-1567-4449</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California at Irvine, 101 The City Drive South, Orange, CA, 92868, USA. vkimonis@uci.edu.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders, Nashville, TN, USA. vkimonis@uci.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <DataBankList CompleteYN="Y">\n                <DataBank>\n                    <DataBankName>ClinicalTrials.gov</DataBankName>\n                    <AccessionNumberList>\n                        <AccessionNumber>NCT00348933</AccessionNumber>\n                    </AccessionNumberList>\n                </DataBank>\n            </DataBankList>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>U54 HD083211</GrantID>\n                    <Acronym>HD</Acronym>\n                    <Agency>NICHD NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>UL1 TR001414</GrantID>\n                    <Acronym>TR</Acronym>\n                    <Agency>NCATS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>U54 RR019478</GrantID>\n                    <Acronym>GF</Acronym>\n                    <Agency>NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>22</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Orphanet J Rare Dis</MedlineTA>\n            <NlmUniqueID>101266602</NlmUniqueID>\n            <ISSNLinking>1750-1172</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D005765">Gastrointestinal Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>12001-76-2</RegistryNumber>\n                <NameOfSubstance UI="D014803">Vitamin B Complex</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>3SCV180C9W</RegistryNumber>\n                <NameOfSubstance UI="D001622">Betaine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>935E97BOY8</RegistryNumber>\n                <NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D017204" MajorTopicYN="N">Angelman Syndrome</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001622" MajorTopicYN="N">Betaine</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005492" MajorTopicYN="N">Folic Acid</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005765" MajorTopicYN="N">Gastrointestinal Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017384" MajorTopicYN="N">Sequence Deletion</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014430" MajorTopicYN="N">Twins, Monozygotic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014803" MajorTopicYN="N">Vitamin B Complex</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Angelman syndrome</Keyword>\n            <Keyword MajorTopicYN="Y">Betaine</Keyword>\n            <Keyword MajorTopicYN="Y">Deletion</Keyword>\n            <Keyword MajorTopicYN="Y">Folic acid</Keyword>\n            <Keyword MajorTopicYN="Y">Methyl donors</Keyword>\n            <Keyword MajorTopicYN="Y">Methylation</Keyword>\n            <Keyword MajorTopicYN="Y">Silencing</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>25</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>7</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31640736</ArticleId>\n            <ArticleId IdType="doi">10.1186/s13023-019-1216-0</ArticleId>\n            <ArticleId IdType="pii">10.1186/s13023-019-1216-0</ArticleId>\n            <ArticleId IdType="pmc">PMC6806546</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Nat Rev Genet. 2012 Sep;13(9):640-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22847273</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Genet. 2003 Feb;40(2):87-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12566516</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Med Genet A. 2011 Dec;155A(12):2956-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22002941</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Speech Lang Pathol. 2005 Feb;14(1):40-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15966111</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epigenomics. 2015 Oct;7(7):1213-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26585570</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Genet. 2001 Dec;38(12):834-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11748306</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dev Pharmacol Ther. 1981;2(2):80-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7472109</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurotherapeutics. 2015 Jul;12(3):641-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26040994</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Calif School Psychol. 2006;11:7-19</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17502922</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):384-401</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27860204</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Comp Neurol. 2014 Jun 1;522(8):1874-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24254964</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Phys Med Rehabil. 2016 Oct;95(10):746-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27088469</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Bone Miner Res. 2000 Nov;15(11):2276-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11092410</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 1982 Nov;107(5):597-602</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6751375</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Ther Targets. 2016;20(5):601-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26558806</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Speech Lang Pathol. 2011 Aug;20(3):200-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21478278</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Med Genet A. 2010 Aug;152A(8):1994-2001</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20635355</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurochem Res. 2017 Dec;42(12):3490-3503</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28918494</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'